STOCK TITAN

HeartSciences (HSCS) Stock News

HSCS NASDAQ

HeartSciences Inc. reports developments as a healthcare information technology company advancing electrocardiography through artificial intelligence. The company’s MyoVista Insights platform is a cloud-native, device-agnostic ECG management system designed for workflow efficiency, EHR interoperability and deployment of cleared AI-ECG algorithms in clinical workflows.

Recurring updates include commercialization of MyoVista Insights, customer and reference-site agreements with hospitals, health networks and academic programs, interoperability milestones such as Epic Toolbox designation, financial results and shareholder meeting matters. HeartSciences also discusses its MyoVista wavECG device, which is designed to provide conventional ECG functionality while supporting on-device AI-enabled solutions.

Rhea-AI Summary

Fortitude Mining Holdings announced that its 15-megawatt Aurora, Nebraska, mining facility is participating in Southwest Power Pool wholesale electricity markets.

Participation uses Dispatchable Demand Response, a framework that lets eligible electricity consumers adjust power usage in response to dispatch instructions and market conditions. The Aurora facility is designed to adjust electricity consumption as grid conditions and market signals change. Southern Public Power District serves the facility through a wholesale supply agreement with Nebraska Public Power District.

Fortitude intends the participation to improve its ability to manage power consumption and increase operational flexibility. The company also plans to pursue expansion of its power portfolio while using flexible infrastructure to optimize energy costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.12%
Tags
none
-
Rhea-AI Summary

HeartSciences (Nasdaq: HSCS) has filed its definitive proxy statement for the proposed all-stock business combination with Fortitude Mining Holdings. The filing was made on October 19, 2026. A virtual special shareholder meeting is scheduled for November 19, 2026, at 10:00 a.m. Eastern Time. The board unanimously approved the transaction-related proposals and recommends voting FOR each proposal.

The combined company is expected to operate under the Fortitude brand as a digital asset mining platform focused on Zcash, combining mining operations, data center infrastructure and power assets. Its Class A common stock is expected to trade on Nasdaq as TUDE, subject to listing requirements and Nasdaq approval. Completion also requires HeartSciences shareholder approval and other customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.74%
Tags
-
Rhea-AI Summary

HeartSciences (HSCS) received FDA 510(k) clearance for its MyoVista wavECG device as a 12-lead resting electrocardiograph for healthcare facilities. Clearance K260005 covers ECG signal acquisition and interpretation in adult and pediatric patients, with interpretive statements provided to clinicians on an advisory basis. It does not include an AI-ECG algorithm. HeartSciences does not intend to commercialize the device without a cleared AI-ECG algorithm and has made no commercialization commitment or set a timeline.

The company plans to evaluate potential options for the device and its related intellectual property; its commercial focus remains on MyoVista Insights. HeartSciences expects its proposed business combination with Fortitude Mining Holdings to close in Q4 calendar 2026, subject to closing conditions, including approval by HeartSciences shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.53%
Tags
Rhea-AI Summary

Fortitude, which plans to combine with HeartSciences (Nasdaq: HSCS), secured priority allocation for BITMAIN equipment through a non-binding purchase commitment. The letter of intent covers up to $100 million of next-generation Zcash mining equipment, with shipments expected to start in the second quarter of 2027. A binding purchase agreement depends on final specifications and pricing; purchases can be scaled down or increased subject to availability and BITMAIN’s consent.

DCG increased Fortitude’s credit facility commitment from $50 million to $70 million, leaving approximately $42.7 million available. Fortitude plans to borrow $20 million this week to pay a refundable deposit, expects funding in ZEC, and plans to sell it. After that borrowing, debt drawn would total approximately $47.3 million, with approximately $22.7 million remaining available. DCG may provide additional ZEC funding through FY 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.53%
Tags
crypto
-
Rhea-AI Summary

Fortitude Mining Holdings appointed Kimberly Pittman as Chief Legal Officer, effective September 28, as it prepares for a proposed business combination.

The previously announced combination is with HeartSciences (Nasdaq: HSCS). Pittman joins Fortitude’s executive leadership team and will oversee its legal function, advising management and the board on corporate governance, securities, regulatory, compliance, commercial and strategic matters.

Pittman brings more than 25 years of experience in corporate and securities law, governance and compliance. She most recently served as Chief Legal Officer, General Counsel and Secretary of ReserveOne. Previously, she was Vice President, Deputy General Counsel at HubSpot, with responsibilities including board advisory and mergers and acquisitions. She also held senior legal roles at SmileDirectClub and CBS Corporation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
none
-
Rhea-AI Summary

Fortitude, proposed merger partner of HeartSciences (HSCS), amended its subsidiary’s DCG credit facility, raising the commitment to $50 million.

The commitment increased by $24 million from $26 million. Approximately $31 million of borrowing capacity remains, including approximately $7 million under the initial commitment, subject to facility terms. Parent company Digital Currency Group (DCG) may fund future loans in ZEC instead of cash. ZEC loans would be denominated and repayable in U.S. dollars, with the ZEC valued at transfer. Fortitude expects the remaining commitment to be funded in ZEC and intends to sell any ZEC received to finance mining equipment and facilities.

Fortitude anticipates drawing the approximately $7 million remaining under the initial commitment in ZEC before the end of September 2026. It plans to sell that ZEC to fund payments for previously announced 9,000-unit Zcash machine orders. Its combination with HeartSciences remains proposed, with trading under TUDE anticipated after completion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.43%
Tags
none
Rhea-AI Summary

Fortitude Mining Holdings (HSCS) appointed former Hut 8 chief executive Jaime Leverton as Chief Executive Officer, effective Monday, September 21, succeeding Andrea Childs, who will become Chief Operating Officer.

Leverton is expected to remain CEO after Fortitude’s proposed business combination with HeartSciences, with the combined company anticipated to operate under the Fortitude brand and trade on the Nasdaq Capital Market under ticker “TUDE”, subject to Nasdaq approval. Fortitude is a vertically integrated, Zcash-focused mining platform that mined 72,696 ZEC in the six months ended June 30, 2026, about 28% of network production, and reported second quarter revenue of $20.9 million. The company owns more than 60 MW of power across seven U.S. sites and has agreed to purchase 9,000 Antminer Z15 Pro units, adding about 7.56 GSol/s of Equihash hashrate with shipments expected in the fourth quarter of 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.70%
Tags
none
-
Rhea-AI Summary

HeartSciences (HSCS) reported fiscal first quarter 2027 results, detailed progress on its proposed business combination with Fortitude Mining Holdings, and provided a MyoVista Insights commercialization update.

For FQ1 2027, the company reported no meaningful revenue, a $2.9 million loss from operations (vs. $1.9 million in FQ1 2026), and a $3.2 million net loss (vs. $2.1 million), with a shareholders’ deficit of $2.0 million as of July 31, 2026. Results included about $0.5 million in incremental legal and professional costs tied to the Fortitude transaction, roughly $0.5 million of non-cash share-based compensation, and a $0.3 million inventory reserve related to the MyoVista wavECG device.

The proposed Fortitude merger is expected to close in Q4 2026, subject to conditions. HeartSciences signed its first US MyoVista Insights commercial agreements, added its first third-party FDA-cleared AI-ECG algorithm, expanded its patent portfolio to more than 45 granted patents, and raised about $2.2 million gross/net equity funding plus a $0.2 million debt-for-equity exchange after quarter end.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
-
Rhea-AI Summary

Fortitude, a vertically integrated digital asset miner anchored in Zcash, reported Q2 2026 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, reconciled from a GAAP net loss of ($9.5 million). EBITDA was $4.9 million after adding impairment, depreciation, interest and tax effects.

The company mined approximately 33,646 ZEC at an average operating hash rate of 4.0 GSol/s and now controls 60+ MW of power capacity across seven sites. Fortitude highlighted progress toward a proposed business combination with HeartSciences (Nasdaq: HSCS), expected to close in H2 2026.

On August 12, 2026, Fortitude purchased 411,522 HSCS shares in a private placement for about $1 million at a $2.43 VWAP, a 22% premium to HeartSciences’ closing price, and now holds roughly 9.4% of HeartSciences’ outstanding common stock. The investment is intended to support HeartSciences’ operating expenses ahead of the Proposed Transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
Rhea-AI Summary

HeartSciences (Nasdaq: HSCS; HSCSW) announced that on August 12, 2026, Fortitude Mining Holdings purchased 411,522 shares of HeartSciences common stock in a private placement for an aggregate of approximately $1,000,000. The shares were issued at $2.43 per share, a 22% premium to the closing price on the purchase date.

According to HeartSciences, the shares are standard voting common stock with no additional rights or preferences. The exchange ratio under the existing merger agreement between Fortitude and HeartSciences remains unchanged, and no extra shares will be issued to Fortitude equity holders at closing due to this investment. Following the transaction, Fortitude holds about 9.4% of HeartSciences’ outstanding common stock. The company stated that the investment provides additional working capital and strengthens its balance sheet ahead of the proposed business combination, which is expected to close in the second half of the current calendar year, subject to customary conditions including shareholder approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.48%
Tags

FAQ

What is the current stock price of HeartSciences (HSCS)?

HeartSciences (HSCS) last closed at $2.83.

What is the market cap of HeartSciences (HSCS)?

The market cap of HeartSciences (HSCS) is approximately $14.1M.